|
|
|
|
We studied the attitudes of 238 Texan neurologists regarding the use of recombinant tissue plasminogen activator(rt-PA).The results shows that 38 (16%)had treated stroke patients with rt-PA,and 97%of these would do so again.In the group that had not treated patients,60%would treat if a suitable candidate presented.We conclude that soon after FDA approval of rt-PA two-thirds of the survey respondents were using or were planning to use this therapy.Those neurologists who have used rt-PA for stroke report a positive experience. |
|